Pharmacologic Equivalence

Pharmacologic Equivalence is a pharmacologic property signifying that two or more drug products contain the same active ingredient, in the same dosage form and route of administration, and exhibit identical physicochemical properties, thereby ensuring comparable biologic activity in the absence of formulation-related differences.

51

Publications

2.1K

Citations

206

Authors

100

Institutions

Publications per year

2017–2026

5

Variants

Pharmaceutical Equivalence

Authors

206

  1. DJ
    Daan J.A. Crommelin

    Utrecht University, Netherlands

    4 publications · 222 citations

    4

    h-index

  2. VP
    Vinod P. Shah

    Center for Drug Evaluation and Research, United States

    3 publications · 111 citations

    3

    h-index

  3. HB
    Henning Blume

    SocraTec R&D (Germany), Germany

    3 publications · 67 citations

    3

    h-index

  4. JD
    Jennifer Dressman

    Goethe University Frankfurt, Germany

    3 publications · 67 citations

    3

    h-index

  5. DB
    Dennis Bashaw

    Goethe University Frankfurt, Germany

    2 publications · 43 citations

    2

    h-index

1–5 of 206

Venues

  1. PubMed

    Repository · 5 publications · 147 citations

    5

    h-index

  2. Journal of Cardiovascular Pharmacology

    2 publications · 37 citations

    2

    h-index

  3. JAMA

    2 publications · 67 citations

    2

    h-index

  4. British Journal of Clinical Pharmacology

    BJCP · 2 publications · 146 citations

    2

    h-index

  5. 2

    h-index

1–5